Fixed-dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: An opportunity to improve adherence and patient care

Diabetic Medicine

Volumn 27, Issue 7, 2010, Pages 739-743

  Schernthaner, G ^a  

^a KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

Author keywords

fixed dose combination formulations; oral glucose lowering agents; Type 2 diabetes

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; COMPETACT; GLIBENCLAMIDE; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE PLUS PIOGLITAZONE; GLIMEPIRIDE PLUS ROSIGLITAZONE; GLIPIZIDE PLUS METFORMIN; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; METFORMIN; METFORMIN PLUS PIOGLITAZONE; METFORMIN PLUS REPAGLINIDE; METFORMIN PLUS ROSIGLITAZONE; METFORMIN PLUS SITAGLIPTIN; METFORMIN PLUS VILDAGLIPTIN; OCTOPLUS MET; PRANDIMET; REPAGLINIDE; ROSIGLITAZONE; TANDEMACT; UNCLASSIFIED DRUG;

DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GLYCEMIC CONTROL; HEALTH CARE COST; HUMAN; HYPERGLYCEMIA; MONOTHERAPY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PATIENT COMPLIANCE; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MEDICATION ADHERENCE; PATIENT CARE;

EID: 77954269930     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2010.03000.x     Document Type: Review

References (30)

1. Lerman I. Adherence to treatment: the key for avoiding long-term complications of diabetes. Arch Med Res 2005 36 : 300 306.
2. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005 353 : 487 497.
3. Leichter SB. Making outpatient care of diabetes more efficient: analyzing noncompliance. Clin Diabetes 2005 23 : 187 190.
4. Odegard PS, Capoccia K. Medication taking and diabetes: a systematic review of the literature. Diabetes Educ 2007 33 : 1014 1029.
5. Bailey CJ, Day C. Fixed-dose single tablet antidiabetic combinations. Diabetes Obes Metab 2009 11 : 527 533.
6. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care 2004 27 : 1218 1224.
7. Paes AH, Bakker A, Soe-Agnie CJ. Impact of dosage frequency on patient compliance. Diabetes Care 1997 20 : 1512 1517.
8. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med 2002 19 : 279 284.
9. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res 2002 30 : 71 79.
10. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a Medicaid patient population with type 2 diabetes mellitus. Clin Ther 2001 23 : 1311 1320.
11. Boccuzzi SJ, Wogen J, Fox J, Sung JC, Shah AB, Kim J. Utilization of oral hypoglycemic agents in a drug-insured US population. Diabetes Care 2001 24 : 1411 1415.
12. Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Whitmire JT, Anderson RT. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis. Curr Med Res Opin 2004 20 : 1633 1640.
13. Guillausseau PJ. Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice. Diabetes Metab 2003 29 : 79 81.
14. 1c goal attainment for HMO patients enrolled in a diabetes disease management program. J Manag Care Pharm 2006 12 : 466 471.
15. Rozenfeld Y, Hunt JS, Plauschinat C, Wong KS. Oral antidiabetic medication adherence and glycemic control in managed care. Am J Manag Care 2008 14 : 71 75.
16. Pladevall M, Williams LK, Potts LA, Divine G, Xi H, Lafata JE. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care 2004 27 : 2800 2805.
17. Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care 2002 25 : 1015 1021.
18. Ho PM, Rumsfeld JS, Masoudi FA, McClure DL, Plomondon ME, Steiner JF et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med 2006 166 : 1836 1841.
19. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care 2004 27 : 2149 2153.
20. Shenolikar RA, Balkrishnan R. Oral antidiabetes medication adherence and health care utilization among Medicaid-enrolled type 2 diabetic patients beginning monotherapy. Diabetes Care 2008 31 : e5.
21. Salas M, Hughes D, Zuluaga A, Vardeva K, Lebmeier M. Costs of medication nonadherence in patients with diabetes mellitus: a systematic review and critical analysis of the literature. Value Health 2009 12 : 915 922.
22. Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT. Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study. Clin Ther 2003 25 : 2958 2971.
23. Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, combination therapy, and fixed-dose combination therapy. Clin Ther 2002 24 : 460 467.
24. Pan F, Chernew ME, Fendrick AM. Impact of fixed-dose combination drugs on adherence to prescription medications. J Gen Intern Med 2008 23 : 611 614.
25. Vanderpoel DR, Hussein MA, Watson-Heidari T, Perry A. Adherence to a fixed-dose combination of rosiglitazone maleate/metformin hydrochloride in subjects with type 2 diabetes mellitus: a retrospective database analysis. Clin Ther 2004 26 : 2066 2075.
26. Leslie RS, Gwadry-Sridhar F, Patel BV, Sanchez-Trask L. Retrospective comparison of compliance and persistence to fixed-dose combination versus single agent combination therapy for the treatment of diabetes. J Manag Care Pharm 2009 15 : 598.
27. Cheong C, Barner JC, Lawson KA, Johnsrud MT. Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among Texas Medicaid recipients. Clin Ther 2008 30 : 1893 1907.
28. 1c in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin. Diabetes Obes Metab 2003 5 : 424 431.
29. Duckworth W, Marcelli M, Padden M, Kellick K, Duhancik T, Wilhardt M et al. Improvements in glycemic control in type 2 diabetes patients switched from sulfonylurea coadministered with metformin to glyburide-metformin tablets. J Manag Care Pharm 2003 9 : 256 262.
30. Leichter SB, Thomas S. Combination medications in diabetes care: an opportunity that merits more attention. Clin Diabetes 2003 21 : 175 178.